- Lobbying
- Lobbying by ST. BALDRICK'S FOUNDATION
Lobbying Relationship
Bills mentioned
H.R.3391: Gabriella Miller Kids First Research Act 2.0
Sponsor: Jennifer Wexton (D-Va.)
S.1624: Gabriella Miller Kids First Research Act 2.0
Sponsor: Tim Kaine (D-Va.)
H.R.3663: SOAR Permanent Authorization Act
Sponsor: John Moolenaar (R-Mich.)
H.R.4363: Comprehensive Cancer Survivorship Act
Sponsor: Debbie Wasserman Schultz (D-Fla.)
S.2213: Comprehensive Cancer Survivorship Act
Sponsor: Amy Klobuchar (D-Minn.)
H.R.4758: Accelerating Kids’ Access to Care Act
Sponsor: Lori Trahan (D-Mass.)
S.2372: Accelerating Kids’ Access to Care Act
Sponsor: Charles E. Grassley (R-Iowa)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Sarah Milberg | Director of Government Relations and Advocacy |
KEVIN MATHIS | n/a |
Rosalie Abbott | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Natl Institutes of Health (NIH)
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate